Cytogel Pharma, LLC
Amendment
CIK: 0001491841·Pharmaceuticals·CONNECTICUT·Filed: Oct 11, 2024
Total Offering
$2,193,276
Amount Sold
$1,763,884
Investors
18
First Sale
Jun 10, 2023
Offering Details
- Type
- Equity, Option to Acquire
- Exemptions
- Rule 506(b)
- Entity Type
- Limited Liability Company
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| C. Dean Maglaris | Related Person |
| Jerry P. Leamon | Related Person |
| Cassandra Klimp | Related Person |
| Frederick W. Telling | Related Person |
| Steven Chrust | Related Person |
| Michael Ullmann | Related Person |
| Eric Lang | Related Person |
| Theodore Maione | Related Person |
Company
SEC Filing
0001213900-24-087167
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free